Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Due to rising medication costs, many patients are forced to abandon their treatments. Additionally, the significant lack of ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Generative AI drug discovery hub Converge Bio raises $5.5M to understand the 'language of biology' - SiliconANGLE ...

Discriminative AI, including machine learning and deep learning, is reshaping traditional industries while GenAI is starting ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

The integration of AI with Ayurveda offers promising advancements in personalized healthcare. AI-enhanced diagnostic tools, ...

Ramy Farid of Schrödinger maintains that AI drug discovery won't work unless physics-based calculations are part of the ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

I am organizing a week-long faculty development program (FDP) on "Artificial Intelligence-based Drug Design" from 10-15 March 2025 at IIITDM Jabalpur. This is open to all teachers (IIT ...